These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25419432)

  • 1. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.
    Zhang H; Dong P; Yang X; Liu Z
    Int J Clin Exp Med; 2014; 7(10):3777-88. PubMed ID: 25419432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.
    Liang Z; Jiang W; Ouyang M; Yang K
    Int J Clin Exp Med; 2015; 8(2):2097-107. PubMed ID: 25932140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
    Li YY
    PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
    Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
    Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
    Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ
    Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
    Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
    Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.
    Anderson JL; Muhlestein JB; Habashi J; Carlquist JF; Bair TL; Elmer SP; Davis BP
    J Am Coll Cardiol; 1999 Nov; 34(6):1778-83. PubMed ID: 10577569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
    Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH
    Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.
    Xu X; Xie Y; Lin Y; Xu X; Zhu Y; Mao Y; Hu Z; Wu J; Chen H; Zheng X; Qin J; Xie L
    Exp Ther Med; 2012 Dec; 4(6):1127-1133. PubMed ID: 23226787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis.
    Tabaei S; Omraninava M; Mehranfar S; Motallebnezhad M; Tabaee SS
    Biochem Genet; 2022 Oct; 60(5):1409-1445. PubMed ID: 35039979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
    Nie W; Li B; Xiu QY
    PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
    Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
    Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
    Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
    PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.
    Zhang X; Gao B; Xu B
    Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease.
    Margaglione M; Cappucci G; Colaizzo D; Giuliani N; Vecchione G; Grandone E; Pennelli O; Di Minno G
    Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):152-6. PubMed ID: 9484978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.
    Xu K; Liu X; Yang F; Cui D; Shi Y; Shen C; Tang W; Yang T
    PLoS One; 2013; 8(11):e79150. PubMed ID: 24223897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Contributes to Osteonecrosis of the Femoral Head Susceptibility: Evidence from a Systematic Review and Meta-analysis.
    Sobhan MR; Mahdinezhad-Yazdi M; Moghimi M; Aghili K; Jafari M; Zare-Shehneh M; Neamatzadeh H
    Arch Bone Jt Surg; 2018 Nov; 6(6):468-477. PubMed ID: 30637301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis.
    Huang Z; Tang W; Liang Z; Chen Q; Li M; Li Y; Lao S; Pan H; Huang L; Huang M; Hu X; Zhao J
    Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk.
    Zhao L; Huang P
    Int J Clin Exp Med; 2013; 6(8):632-40. PubMed ID: 24040470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
    Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
    Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.